chr2-177232457-A-C
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_006164.5(NFE2L2):āc.529T>Gā(p.Leu177Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000334 in 1,614,130 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L177S) has been classified as Uncertain significance.
Frequency
Consequence
NM_006164.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NFE2L2 | NM_006164.5 | c.529T>G | p.Leu177Val | missense_variant | 4/5 | ENST00000397062.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NFE2L2 | ENST00000397062.8 | c.529T>G | p.Leu177Val | missense_variant | 4/5 | 1 | NM_006164.5 | A1 |
Frequencies
GnomAD3 genomes AF: 0.00179 AC: 273AN: 152200Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000462 AC: 115AN: 248914Hom.: 0 AF XY: 0.000318 AC XY: 43AN XY: 135076
GnomAD4 exome AF: 0.000182 AC: 266AN: 1461812Hom.: 1 Cov.: 30 AF XY: 0.000157 AC XY: 114AN XY: 727206
GnomAD4 genome AF: 0.00179 AC: 273AN: 152318Hom.: 1 Cov.: 33 AF XY: 0.00161 AC XY: 120AN XY: 74490
ClinVar
Submissions by phenotype
not specified Benign:1Other:1
Benign, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The NFE2L2 p.L177V variant was identified in 1/1362 proband chromosomes (allele frequency: 0.0007) from a healthy population (Bodian_2014_PMID: 24728327). The variant was identified in dbSNP (ID: rs35577826) and ClinVar (classified as benign by Invitae). The variant was identified in control databases in 174 of 280318 chromosomes (0 homozygous) at a frequency of 0.0006207, and was observed at the highest frequency in the African population in 169 of 24140 chromosomes (freq: 0.007001) (Genome Aggregation Database March 6, 2019, v2.1.1). This frequency is greater than expected for the rare, autosomal dominant immunodeficiency, developmental delay, and hypohomocysteinemia condition associated with NFE2L2 variants. The p.L177 residue is not conserved in mammals and computational analyses (MUT Assesor, PolyPhen-2, SIFT, MutationTaster, Revel, FATHMM, MetaLR, DANN) do not suggest a high likelihood of impact to the protein; this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (Splice AI exome) do not predict an effect on splicing. In summary, based on the above information this variant meets our laboratory's criteria to be classified as benign. - |
not provided, no classification provided | reference population | ITMI | Sep 19, 2013 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 23, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at